Diseases & Illness |

Cancer News

Avastin Found Ineffective for Pancreatic Cancer

RSS News Feeds
Disease from Products
Osteonecrosis of the Jaw (ONJ)
Cancer
Lung Cancer
Failure to Diagnose
Asbestos
Fosamax
Mesothelioma
 All RSS Feeds

At a glance:

Drugmaker Genentech has stopped an experimental trial of the cancer drug Avastin for the treatment of pancreatic cancer. 
 
An independent monitoring board confirmed that the results were not going to meet the goals. 
 
Avastin is approved for treatment of several cancers including colorectal cancer, certain lung cancers and breast cancer. 
 
While Avastin appeared safe, it did not appear to aid in the treatment of pancreatic cancer. 
 
It is still being tested for other types of cancer.

Genentech Stops Avastin Pancreatic Cancer Trial As Results Fail To ...

Trading Markets - 6/27/2006 10:28 AM

(RTTNews) - Tuesday, Biotech drug maker, Genentech, Inc. announced that it had stopped the Phase III pancreatic cancer clinical trial after deciding its cancer drug, Avastin, did not meet its primary endpoint of overall survival. The company stopped the trial at the recommendation of an independent data monitoring board that decided that a significant improvement would be unlikely given the data already collected. Genentech said the trial was not stopped for safety reasons. In the first quarter, U.S. sales of Avastin jumped 96% to $398 million from $203 million in the year-ago quarter.
 
· Read The Full Cancer Article From Trading Markets -->

· Read All Cancer News Stories -->

Comments On Cancer News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: